FDA Inspection 1083359 — HRF, Inc

HRF, Inc — FEI 1053497

The FDA completed an inspection of HRF, Inc on March 20, 2019 in Raleigh, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 20, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Raleigh, NC (United States)

Citations

IDCFRDescription
1808521 CFR 630.10(f)(3)Physical Assessment Determination - Hemoglobin or Hematocrit
8021 CFR 606.100(b)(1)Donor criteria
907621 CFR 600.12(a)Maintenance - concurrence